{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:39:55Z","timestamp":1761507595326,"version":"build-2065373602"},"reference-count":122,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Paediatric Respiratory Reviews"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.prrv.2023.08.003","type":"journal-article","created":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T03:24:06Z","timestamp":1692242646000},"page":"30-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Cough medicines for children- time for a reality check"],"prefix":"10.1016","volume":"48","author":[{"given":"Gene","family":"Clark","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic A.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0876-4016","authenticated-orcid":false,"given":"Bruce K.","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.prrv.2023.08.003_b0005","first-page":"761","article-title":"Physiology of airway mucus clearance","volume":"47","author":"Rubin","year":"2002","journal-title":"Respir Care"},{"issue":"6","key":"10.1016\/j.prrv.2023.08.003_b0010","doi-asserted-by":"crossref","first-page":"726","DOI":"10.4187\/002013209790983269","article-title":"Mucus, phlegm, and sputum in cystic fibrosis","volume":"54","author":"Rubin","year":"2009","journal-title":"Respir Care"},{"issue":"12","key":"10.1016\/j.prrv.2023.08.003_b0015","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.4187\/respcare.02925","article-title":"AARC clinical practice guideline: effectiveness of nonpharmacologic airway clearance therapies in hospitalized patients","volume":"58","author":"Strickland","year":"2013","journal-title":"Respir Care"},{"issue":"6","key":"10.1016\/j.prrv.2023.08.003_b0020","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1378\/chest.14-1481","article-title":"Anatomy and neurophysiology of cough","volume":"146","author":"Canning","year":"2014","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.prrv.2023.08.003_b0025","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-022-00370-w","article-title":"Cough hypersensitivity and chronic cough","volume":"8","author":"Chung","year":"2022","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"10.1016\/j.prrv.2023.08.003_b0030","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1378\/chest.128.4.2427","article-title":"Bronchial sensitivity and bronchial reactivity in children with cough variant asthma","volume":"128","author":"Mochizuki","year":"2005","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.prrv.2023.08.003_b0035","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/pupt.2002.0364","article-title":"The powerful placebo in cough studies?","volume":"15","author":"Eccles","year":"2002","journal-title":"Pulm Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.prrv.2023.08.003_b0040","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1378\/chest.118.4.1150","article-title":"Chicken soup inhibits neutrophil chemotaxis in vitro","volume":"118","author":"Rennard","year":"2000","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.prrv.2023.08.003_b0045","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1378\/chest.08-0095","article-title":"Vicks vaporub induces mucin secretion, decreases ciliary beat frequency, and increases tracheal mucus transport in the ferret trachea","volume":"135","author":"Abanses","year":"2009","journal-title":"Chest"},{"issue":"9853","key":"10.1016\/j.prrv.2023.08.003_b0050","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0140-6736(12)60776-4","article-title":"Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial","volume":"380","author":"Ryan","year":"2012","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.prrv.2023.08.003_b0055","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1164\/rccm.202211-2128LE","article-title":"Efficacy and safety of gefapixant for refractory or unexplained chronic cough over 52 weeks","volume":"207","author":"Birring","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.prrv.2023.08.003_b0060","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1165\/ajrcmb.18.1.2740","article-title":"Stimulation of migration and wound repair of guinea-pig airway epithelial cells in response to epidermal growth factor","volume":"18","author":"Kim","year":"1998","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"10.1016\/j.prrv.2023.08.003_b0065","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1165\/rcmb.2005-0386OC","article-title":"Epidermal growth factor receptor activation by epidermal growth factor mediates oxidant-induced goblet cell metaplasia in human airway epithelium","volume":"34","author":"Casalino-Matsuda","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"10.1016\/j.prrv.2023.08.003_b0070","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3810\/pgm.2008.07.1791","volume":"120","author":"LaForce","year":"2008","journal-title":"Postgrad Med"},{"issue":"11","key":"10.1016\/j.prrv.2023.08.003_b0075","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.rmed.2015.09.017","article-title":"Effect of a single 1200 Mg dose of Mucinex \u00ae on mucociliary and cough clearance during an acute respiratory tract infection","volume":"109","author":"Bennett","year":"2015","journal-title":"Respir Med"},{"key":"10.1016\/j.prrv.2023.08.003_b0080","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.resp.2018.01.008","article-title":"Inhibitors of phosphodiesterases in the treatment of cough","volume":"257","author":"Mokry","year":"2018","journal-title":"Respir Physiol Neurobiol"},{"issue":"7","key":"10.1016\/j.prrv.2023.08.003_b0085","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.21037\/jtd.2017.06.18","article-title":"Theobromine for the treatment of persistent cough: a randomised, multicentre, double-blind, placebo-controlled clinical trial","volume":"9","author":"Morice","year":"2017","journal-title":"J Thorac Dis"},{"issue":"1","key":"10.1016\/j.prrv.2023.08.003_b0090","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1586\/ers.12.72","article-title":"Effect of inhaled dry powder mannitol on mucus and its clearance","volume":"7","author":"Daviskas","year":"2013","journal-title":"Expert Rev Respir Med"},{"issue":"1","key":"10.1016\/j.prrv.2023.08.003_b0095","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1440-1843.2005.00659.x","article-title":"Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: Effect on lung function, health status and sputum","volume":"10","author":"Daviskas","year":"2005","journal-title":"Respirology"},{"issue":"17","key":"10.1016\/j.prrv.2023.08.003_b0100","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1001\/jama.1997.03550170056032","article-title":"Effects of aerosolized surfactant in patients with stable chronic bronchitis: a prospective randomized controlled trial","volume":"278","author":"Anzueto","year":"1997","journal-title":"J Am Med Assoc"},{"issue":"4","key":"10.1016\/j.prrv.2023.08.003_b0105","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/00039896.1974.10666572","article-title":"Increased mucociliary transport by cholinergic stimulation","volume":"29","author":"Camner","year":"1974","journal-title":"Arch Environ Health: Int J"},{"issue":"2","key":"10.1016\/j.prrv.2023.08.003_b0110","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0034-5687(93)90039-D","article-title":"Cholinergic and adrenergic stimulation of mucociliary transport in the rat trachea","volume":"92","author":"Gatto","year":"1993","journal-title":"Respir Physiol"},{"issue":"2","key":"10.1016\/j.prrv.2023.08.003_b0115","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1152\/jappl.1976.41.2.146","article-title":"Effect of adrenergic agents and their mode of action on mucociliary clearance in man","volume":"41","author":"Foster","year":"1976","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.prrv.2023.08.003_b0120","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.resp.2018.01.011","article-title":"Inhibitory modulation of the cough reflex by acetylcholine in the caudal nucleus tractus solitarii of the rabbit","volume":"257","author":"Cinelli","year":"2018","journal-title":"Respir Physiol Neurobiol"},{"issue":"1","key":"10.1016\/j.prrv.2023.08.003_b0125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/(SICI)1099-0496(199901)27:1<3::AID-PPUL2>3.0.CO;2-A","article-title":"Who will benefit from DNase?","volume":"27","author":"Rubin","year":"1999","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.prrv.2023.08.003_b0130","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004232.pub2","article-title":"Inhaled corticosteroids for non-specific chronic cough in children","author":"Tomerak","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.prrv.2023.08.003_b0135","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001726.pub5","article-title":"Beta2-agonists for acute cough or a clinical diagnosis of acute bronchitis","author":"Becker","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.prrv.2023.08.003_b0140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1378\/chest.63.1.9","article-title":"The expectorant effect of glyceryl guaiacolate in patients with chronic bronchitis. A controlled in vitro and in vivo study","volume":"63","author":"Hirsch","year":"1973","journal-title":"Chest"},{"issue":"9470","key":"10.1016\/j.prrv.2023.08.003_b0145","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0140-6736(05)66456-2","article-title":"Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial","volume":"365","author":"Decramer","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.prrv.2023.08.003_b0150","unstructured":"Jaques A, Tozer L. A phase III multicentre, randomised, parallel, placebo-controlled, double blind study to investigate the safety and efficacy of dry powder mannitol in the symptomatic treatment of bronchiectasis. Frenchs Forest, New South Wales 2086, Australia; 2008."},{"key":"10.1016\/j.prrv.2023.08.003_b0155","unstructured":"Bucelli, Pinelli, Amoretti. https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2006-004048-21\/results. 2010. CSR synopsis 7171L01."},{"issue":"1","key":"10.1016\/j.prrv.2023.08.003_b0160","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1378\/chest.12-1763","article-title":"Phase 3 randomized study of the efficacy and safety of inhaled dry powder mannitol for the symptomatic treatment of non-cystic fibrosis bronchiectasis","volume":"144","author":"Bilton","year":"2013","journal-title":"Chest"},{"issue":"7-8","key":"10.1016\/j.prrv.2023.08.003_b0165","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s00508-014-0692-4","article-title":"N-acetylcysteine in patients with COPD exacerbations associated with increased sputumN-Acetylcystein bei Patienten mit Exazerbation einer COPD mit erh\u00f6hter Sputumproduktion","volume":"127","author":"Ayfer Aytemur","year":"2015","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.prrv.2023.08.003_b0170","doi-asserted-by":"crossref","unstructured":"Johnson K, McEvoy C, Naqvi S, Wendt C, Reilkoff R, Kunisaki K, et al. High-dose oral N-acetylcysteine fails to improve respiratory health status in patients with chronic obstructive pulmonary disease and chronic bronchitis: a randomized, placebo-controlled trial. Int J Chron Obstruct Pulmon Dis. 2016 Apr 21;11:799\u2013807.","DOI":"10.2147\/COPD.S102375"},{"key":"10.1016\/j.prrv.2023.08.003_b0175","unstructured":"Armogida M. https:\/\/clinicaltrials.gov\/study\/NCT02379637?tab=results. 2016. Study to Evaluate the Efficacy of N-acetylcysteine (NAC) in the Treatment of the Common Cold and Cough (NAC cold cough)."},{"issue":"1","key":"10.1016\/j.prrv.2023.08.003_b0180","article-title":"Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials","volume":"3","author":"McGarvey","year":"2016","journal-title":"BMJ Open Respir Res"},{"issue":"2","key":"10.1016\/j.prrv.2023.08.003_b0185","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1378\/chest.13-2609","article-title":"Secretory hyperresponsiveness and pulmonary mucus hypersecretion","volume":"146","author":"Rubin","year":"2014","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.prrv.2023.08.003_b0190","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0002-9343(86)90458-4","article-title":"Effect of ipratropium bromide on airway mucociliary function","volume":"81","author":"Wanner","year":"1986","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.prrv.2023.08.003_b0195","first-page":"201","article-title":"Regulation of bronchial tone in chronic obstructive pulmonary disease (COPD): role of muscarinic receptors","volume":"20","author":"Abad Santos","year":"2003","journal-title":"An Med Interna"},{"issue":"4","key":"10.1016\/j.prrv.2023.08.003_b0200","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1513\/pats.200504-043SR","article-title":"Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease","volume":"2","author":"Belmonte","year":"2005","journal-title":"Proc Am Thorac Soc"},{"issue":"1","key":"10.1016\/j.prrv.2023.08.003_b0205","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0163-7258(03)00004-4","article-title":"Muscarinic acetylcholine receptors and airway diseases","volume":"98","author":"Coulson","year":"2003","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.prrv.2023.08.003_b0210","unstructured":"Lowry RH. A Physiological Model of the Human Cough Reflex: Investigations of the Afferent Pathway and Antitussive Studies."},{"key":"10.1016\/j.prrv.2023.08.003_b0215","doi-asserted-by":"crossref","unstructured":"Basbaum C, Li D, Gensch E, Gallup M, Lemjabbar H. Mechanisms by which gram-positive bacteria and tobacco smoke stimulate mucin induction through the epidermal growth factor receptor (EGFR). Novartis Found Symp. 2002;248:171\u20136; discussion 176-80, 277\u201382.","DOI":"10.1002\/0470860790.ch11"},{"issue":"11","key":"10.1016\/j.prrv.2023.08.003_b0220","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1136\/thx.2003.018879","article-title":"Roles of epidermal growth factor receptor activation in epithelial cell repair and mucin production in airway epithelium","volume":"59","author":"Burgel","year":"2004","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.prrv.2023.08.003_b0225","doi-asserted-by":"crossref","first-page":"L75","DOI":"10.1152\/ajplung.00093.2005","article-title":"Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells","volume":"290","author":"Shinkai","year":"2006","journal-title":"Am J Physiol-Lung Cell Mol Physiol"},{"issue":"12","key":"10.1016\/j.prrv.2023.08.003_b0230","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1136\/thx.2010.142711","article-title":"Long-term low-dose erythromycin in patients with unexplained chronic cough: a double-blind placebo controlled trial","volume":"65","author":"Yousaf","year":"2010","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.prrv.2023.08.003_b0235","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1465-9921-14-125","article-title":"Azithromycin and cough-specific health status in patients with chronic obstructive pulmonary disease and chronic cough: a randomised controlled trial","volume":"14","author":"Berkhof","year":"2013","journal-title":"Respir Res"},{"issue":"4","key":"10.1016\/j.prrv.2023.08.003_b0240","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.chest.2015.12.036","article-title":"The effects of azithromycin in treatment-resistant cough","volume":"149","author":"Hodgson","year":"2016","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.prrv.2023.08.003_b0245","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1513\/AnnalsATS.202103-266OC","article-title":"Azithromycin for the treatment of chronic cough in idiopathic pulmonary fibrosis: a randomized controlled crossover trial","volume":"18","author":"Guler","year":"2021","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"10.1016\/j.prrv.2023.08.003_b0250","first-page":"95","article-title":"The treatment of acute transient cough: a placebo-controlled comparison of dextromethorphan and dextromethorphan-beta 2-sympathomimetic combination","volume":"69","author":"Tukiainen","year":"1986","journal-title":"Eur J Respir Dis"},{"issue":"5","key":"10.1016\/j.prrv.2023.08.003_b0255","first-page":"476","article-title":"A comparison of albuterol and erythromycin for the treatment of acute bronchitis","volume":"33","author":"Hueston","year":"1991","journal-title":"J Fam Pract"},{"issue":"3","key":"10.1016\/j.prrv.2023.08.003_b0260","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/fampra\/8.3.216","article-title":"Symptomatic effect of inhaled fenoterol in acute bronchitis: a placebo-controlled double-blind study","volume":"8","author":"Melbye","year":"1991","journal-title":"Fam Pract"},{"issue":"10","key":"10.1016\/j.prrv.2023.08.003_b0265","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1651-2227.1991.tb11764.x","article-title":"Antitussives in the treatment of acute transient cough in children","volume":"80","author":"Korppi","year":"1991","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.prrv.2023.08.003_b0270","unstructured":"Littenberg B, Wheeler M, Smith DS. A randomized controlled trial of oral albuterol in acute cough. Vol. 42, From: Journal of Family Practice. 1996."},{"issue":"1","key":"10.1016\/j.prrv.2023.08.003_b0275","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/adc.79.1.6","article-title":"A randomised, placebo controlled trial of inhaled salbutamol and beclomethasone for recurrent cough","volume":"79","author":"Chang","year":"1998","journal-title":"Arch Dis Child"},{"issue":"1","key":"10.1016\/j.prrv.2023.08.003_b0280","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/adc.81.1.38","article-title":"Persistent nocturnal cough: randomised controlled trial of high dose inhaled corticosteroid","volume":"81","author":"Davies","year":"1999","journal-title":"Arch Dis Child"},{"issue":"4","key":"10.1016\/j.prrv.2023.08.003_b0285","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1651-2227.1999.tb01142.x","article-title":"Is oral albuterol effective for acute cough in non-asthmatic children?","volume":"88","author":"Bernard","year":"2007","journal-title":"Acta Paediatr"},{"issue":"1","key":"10.1016\/j.prrv.2023.08.003_b0290","doi-asserted-by":"crossref","DOI":"10.1186\/1745-9974-10-2","article-title":"A real \u2013 life observational pilot study to evaluate the effects of two-week treatment with montelukast in patients with chronic cough","volume":"10","author":"Mincheva","year":"2014","journal-title":"Cough"},{"issue":"3","key":"10.1016\/j.prrv.2023.08.003_b0295","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s11096-015-0081-8","article-title":"Inhibition of cough reflex sensitivity by diphenhydramine during acute viral respiratory tract infection","volume":"37","author":"Dicpinigaitis","year":"2015","journal-title":"Int J Clin Pharm"},{"issue":"10","key":"10.1016\/j.prrv.2023.08.003_b0300","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S2213-2600(17)30310-7","article-title":"A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial","volume":"5","author":"Birring","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.prrv.2023.08.003_b0305","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.2147\/COPD.S292109","article-title":"Management of cough in patients with chronic obstructive pulmonary disease: results of the multicenter randomized placebo-controlled clinical trial","volume":"16","author":"Avdeev","year":"2021","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"3","key":"10.1016\/j.prrv.2023.08.003_b0310","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1378\/chest.15-0022","article-title":"A randomized trial of 1% vs 2% lignocaine by the spray-as-you-go technique for topical anesthesia during flexible bronchoscopy","volume":"148","author":"Kaur","year":"2015","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.prrv.2023.08.003_b0315","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.chest.2019.06.018","article-title":"A randomized trial of nebulized lignocaine, lignocaine spray, or their combination for topical anesthesia during diagnostic flexible bronchoscopy","volume":"157","author":"Dhooria","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.prrv.2023.08.003_b0320","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.coph.2015.03.002","article-title":"NMDA and GABA receptors as potential targets in cough hypersensitivity syndrome","volume":"22","author":"Chung","year":"2015","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"10.1016\/j.prrv.2023.08.003_b0325","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.4187\/respcare.03255","article-title":"Gabapentin as a potential treatment for cough syncope","volume":"60","author":"Wu","year":"2015","journal-title":"Respir Care"},{"issue":"31","key":"10.1016\/j.prrv.2023.08.003_b0330","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000007640","article-title":"The identification of the TRPM8 channel on primary culture of human nasal epithelial cells and its response to cooling","volume":"96","author":"Liu","year":"2017","journal-title":"Medicine"},{"issue":"19","key":"10.1016\/j.prrv.2023.08.003_b0335","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1111\/bph.15531","article-title":"Inhibition of inflammatory pain and cough by a novel charged sodium channel blocker","volume":"178","author":"Tochitsky","year":"2021","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.prrv.2023.08.003_b0340","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00408-020-00377-8","article-title":"P2X3-receptor antagonists as potential antitussives: summary of current clinical trials in chronic cough","volume":"198","author":"Dicpinigaitis","year":"2020","journal-title":"Lung"},{"issue":"2","key":"10.1016\/j.prrv.2023.08.003_b0345","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00408-023-00606-w","article-title":"The efficacy and safety of gefapixant in a phase 3b trial of patients with recent-onset chronic cough","volume":"201","author":"McGarvey","year":"2023","journal-title":"Lung"},{"issue":"10328","key":"10.1016\/j.prrv.2023.08.003_b0350","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0140-6736(21)02348-5","article-title":"Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials","volume":"399","author":"McGarvey","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.prrv.2023.08.003_b0355","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1745-9974-3-8","article-title":"Central and peripheral mechanisms of narcotic antitussives: codeine-sensitive and -resistant coughs","volume":"3","author":"Takahama","year":"2007","journal-title":"Cough"},{"issue":"S1","key":"10.1016\/j.prrv.2023.08.003_b0360","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00408-009-9197-8","article-title":"The efficacy of a NOP1 agonist (SCH486757) in subacute cough","volume":"188","author":"Woodcock","year":"2010","journal-title":"Lung"},{"issue":"10","key":"10.1016\/j.prrv.2023.08.003_b0365","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.2042-7158.1997.tb06039.x","article-title":"Assessment of the antitussive efficacy of codeine in cough associated with common cold","volume":"49","author":"Freestone","year":"2011","journal-title":"J Pharm Pharmacol"},{"issue":"6","key":"10.1016\/j.prrv.2023.08.003_b0370","doi-asserted-by":"crossref","first-page":"398","DOI":"10.7326\/0003-4819-157-6-201209180-00003","article-title":"Thalidomide for the treatment of cough in idiopathic pulmonary fibrosis","volume":"157","author":"Horton","year":"2012","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.prrv.2023.08.003_b0375","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s12630-014-0295-6","article-title":"Efficacy of a single dose of dexmedetomidine for cough suppression during anesthetic emergence: a randomized controlled trial","volume":"62","author":"Lee","year":"2015","journal-title":"Canad J Anesthesia\/J canadien d\u2019anesth\u00e9sie"},{"issue":"9974","key":"10.1016\/j.prrv.2023.08.003_b0380","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0140-6736(14)61255-1","article-title":"P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study","volume":"385","author":"Abdulqawi","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.prrv.2023.08.003_b0385","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1378\/chest.15-0817","article-title":"Effect of e-cigarette use on cough reflex sensitivity","volume":"149","author":"Dicpinigaitis","year":"2016","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.prrv.2023.08.003_b0390","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/s12630-016-0652-8","article-title":"Intracuff 160 mg alkalinized lidocaine reduces cough upon emergence from N2O-free general anesthesia: a randomized controlled trial","volume":"63","author":"Souissi","year":"2016","journal-title":"Canad J Anesthesia\/J Canadien d\u2019anesth\u00e9sie"},{"key":"10.1016\/j.prrv.2023.08.003_b0395","doi-asserted-by":"crossref","unstructured":"Smith JA, McGarvey LPA, Badri H, Satia I, Warren F, Siederer S, et al. Effects of a novel sodium channel blocker, GSK2339345, in patients with refractory chronic cough. Int J Clin Pharmacol Therapeutics. 2017.","DOI":"10.5414\/CP202804"},{"issue":"10","key":"10.1016\/j.prrv.2023.08.003_b0400","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1164\/rccm.201704-0769OC","article-title":"XEN-D0501, a novel transient receptor potential vanilloid 1 antagonist, does not reduce cough in patients with refractory cough","volume":"196","author":"Belvisi","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.prrv.2023.08.003_b0405","unstructured":"Martinez FJ, Rabe KF, Pizzichini E, Mcivor A, Anzueto A, Alagappan V, et al. Effect Of Roflumilast On Cough And Sputum In Patients With Severe Or Very Severe Chronic Obstructive Pulmonary Disease (COPD) Receiving Inhaled Combination Therapy: Evaluation Of The Exacerbation Of Chronic Pulmonary Disease Tool-Patient Reported Outcomes (exact-Pro) Subdomain Scores [Internet]. 2017. Available from: www.gold.copd.org."},{"issue":"1","key":"10.1016\/j.prrv.2023.08.003_b0410","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1213\/ANE.0000000000003842","article-title":"Effect of intravenous lidocaine, dexamethasone, and their combination on postoperative sore throat: a randomized controlled trial","volume":"129","author":"Subedi","year":"2019","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/j.prrv.2023.08.003_b0415","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.chest.2019.08.001","article-title":"The neurokinin-1 receptor antagonist orvepitant is a novel antitussive therapy for chronic refractory cough","volume":"157","author":"Smith","year":"2020","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.prrv.2023.08.003_b0420","doi-asserted-by":"crossref","first-page":"2004240","DOI":"10.1183\/13993003.04240-2020","article-title":"Eliapixant (BAY 1817080), a P2X3 receptor antagonist, in refractory chronic cough: a randomised, placebo-controlled, crossover phase 2a study","volume":"58","author":"Morice","year":"2021","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.prrv.2023.08.003_b0425","first-page":"471","article-title":"Treatment of persistent cough in subjects with idiopathic pulmonary fibrosis (IPF) with Gefapixant, a P2X3 antagonist, in a randomized","volume":"7","author":"Martinez","year":"2021","journal-title":"Placebo-Controlled Clinical Trial Pulm Ther"},{"issue":"6","key":"10.1016\/j.prrv.2023.08.003_b0430","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1164\/rccm.202006-2359OC","article-title":"Aprepitant for cough in lung cancer. a randomized placebo-controlled trial and mechanistic insights","volume":"203","author":"Smith","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.prrv.2023.08.003_b0435","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.alit.2022.05.006","article-title":"A phase 3, randomized, double-blind, clinical study to evaluate the long-term safety and efficacy of gefapixant in Japanese adult participants with refractory or unexplained chronic cough","volume":"71","author":"Niimi","year":"2022","journal-title":"Allergol Int"},{"issue":"1","key":"10.1016\/j.prrv.2023.08.003_b0440","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-023-02384-8","article-title":"The P2X3 receptor antagonist filapixant in patients with refractory chronic cough: a randomized controlled trial","volume":"24","author":"Friedrich","year":"2023","journal-title":"Respir Res"},{"issue":"1","key":"10.1016\/j.prrv.2023.08.003_b0445","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00408-022-00592-5","article-title":"A randomized, double-blind, placebo-controlled, parallel-group phase 2b Trial of P2X3 Receptor antagonist sivopixant for refractory or unexplained chronic cough","volume":"201","author":"McGarvey","year":"2023","journal-title":"Lung"},{"issue":"3","key":"10.1016\/j.prrv.2023.08.003_b0450","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1152\/jappl.1988.65.3.1125","article-title":"Effect of inhaled and systemic opiates on responses to inhaled capsaicin in humans","volume":"65","author":"Fuller","year":"1988","journal-title":"J Appl Physiol"},{"issue":"4","key":"10.1016\/j.prrv.2023.08.003_b0455","first-page":"283","article-title":"Dextromethorphan and codeine: comparison of plasma kinetics and antitussive effects","volume":"65","author":"Aylward","year":"1984","journal-title":"Eur J Respir Dis"},{"issue":"1","key":"10.1016\/j.prrv.2023.08.003_b0460","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.chest.2020.01.042","article-title":"Managing Chronic Cough as a Symptom in Children and Management Algorithms","volume":"158","author":"Chang","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.prrv.2023.08.003_b0465","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007094.pub5","article-title":"Honey for acute cough in children","author":"Oduwole","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.prrv.2023.08.003_b0470","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12519-016-0048-4","article-title":"Efficacy and tolerability of a polysaccharide-resin-honey based cough syrup as compared to carbocysteine syrup for children with colds: a randomized, single-blinded, multicenter study","volume":"13","author":"Cohen","year":"2017","journal-title":"World J Pediatr"},{"issue":"1","key":"10.1016\/j.prrv.2023.08.003_b0475","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1824-7288-40-56","article-title":"Efficacy of Grintuss\u00ae pediatric syrup in treating cough in children: a randomized, multicenter, double blind, placebo-controlled clinical trial","volume":"40","author":"Canciani","year":"2014","journal-title":"Ital J Pediatr"},{"issue":"12","key":"10.1016\/j.prrv.2023.08.003_b0480","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/archpedi.161.12.1140","article-title":"Effect of Honey, Dextromethorphan, and No Treatment on Nocturnal Cough and Sleep Quality for Coughing Children and Their Parents","volume":"161","author":"Paul","year":"2007","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"7","key":"10.1016\/j.prrv.2023.08.003_b0485","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1089\/acm.2009.0311","article-title":"A comparison of the effect of honey, dextromethorphan, and diphenhydramine on nightly cough and sleep quality in children and their parents","volume":"16","author":"Shadkam","year":"2010","journal-title":"J Altern Complement Med"},{"issue":"7","key":"10.1016\/j.prrv.2023.08.003_b0490","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/j.1440-1843.2011.02014.x","article-title":"Chronic cough and esomeprazole: A double-blind placebo-controlled parallel study","volume":"16","author":"Faruqi","year":"2011","journal-title":"Respirology"},{"issue":"3","key":"10.1016\/j.prrv.2023.08.003_b0495","first-page":"465","article-title":"Effect of honey on nocturnal cough and sleep quality: a double-blind, randomized","volume":"130","author":"Cohen","year":"2012","journal-title":"Placebo-Controlled Study Pediatrics"},{"key":"10.1016\/j.prrv.2023.08.003_b0500","unstructured":"Ahmadi M, Moosavi SM, Zakeri Sh. Comparison of the effect of honey and diphenhydramine on cough alleviation in 2-5-year-old children with viral upper respiratory tract infection. Journal of Gorgan University of Medical Sciences [Internet]. 2013 [cited 2023 Aug 4];15(2):8\u201313. Available from: http:\/\/goums.ac.ir\/journal\/article-1-1712-en.html."},{"key":"10.1016\/j.prrv.2023.08.003_b0505","article-title":"Randomized double blind study to compare effectiveness of honey, salbutamol and placebo in treatment of cough in children with common cold","volume":"91","author":"Waris","year":"2014","journal-title":"East Afr Med J"},{"issue":"2","key":"10.1016\/j.prrv.2023.08.003_b0510","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/fampra\/cmac112","article-title":"Effectiveness of antitussives, anticholinergics, and honey versus usual care in adults with uncomplicated acute bronchitis: a multiarm randomized clinical trial","volume":"40","author":"Llor","year":"2023","journal-title":"Fam Pract"},{"issue":"10","key":"10.1016\/j.prrv.2023.08.003_b0515","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/jama.2017.10572","article-title":"Oral corticosteroids for acute lower respiratory infection: are we ready to drop this practice?","volume":"24","author":"Hay","year":"2017","journal-title":"J Am Med Assoc"},{"issue":"1","key":"10.1016\/j.prrv.2023.08.003_b0520","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1365-2222.2007.02871.x","article-title":"Modulation of mucus production by interleukin-13 receptor \u03b12 in the human airway epithelium","volume":"38","author":"Tanabe","year":"2007","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.prrv.2023.08.003_b0525","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2222.2009.03383.x","article-title":"Interleukin-13: prospects for new treatments","volume":"40","author":"Brightling","year":"2010","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.prrv.2023.08.003_b0530","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/intimm\/dxl117","article-title":"IL9 leads to airway inflammation by inducing IL13 expression in airway epithelial cells","volume":"19","author":"Temann","year":"2006","journal-title":"Int Immunol"},{"issue":"10","key":"10.1016\/j.prrv.2023.08.003_b0535","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1172\/JCI6097","article-title":"Allergen-induced IL-9 directly stimulates mucin transcription in respiratory epithelial cells","volume":"104","author":"Longphre","year":"1999","journal-title":"J Clin Investig"},{"key":"10.1016\/j.prrv.2023.08.003_b0540","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008888.pub2","article-title":"Inhaled corticosteroids for subacute cough in children","author":"Anderson-James","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.prrv.2023.08.003_b0545","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00408-008-9114-6","article-title":"Effect of tiotropium on cough reflex sensitivity in acute viral cough","volume":"186","author":"Dicpinigaitis","year":"2008","journal-title":"Lung"},{"issue":"9","key":"10.1016\/j.prrv.2023.08.003_b0550","doi-asserted-by":"crossref","first-page":"410","DOI":"10.5694\/mja2.51865","article-title":"Over\u2010the\u2010counter cough and cold medicines: reported poisonings of children before and after the 2012 and 2020 labelling changes in Australia","volume":"218","author":"Arbaeen","year":"2023","journal-title":"Med J Aust"},{"issue":"3","key":"10.1016\/j.prrv.2023.08.003_b0555","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1542\/peds.108.3.e52","article-title":"Toxicity of over-the-counter cough and cold medications","volume":"108","author":"Gunn","year":"2001","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.prrv.2023.08.003_b0560","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.annemergmed.2008.09.015","article-title":"Pediatric fatalities associated with over the counter (nonprescription) cough and cold medications","volume":"53","author":"Dart","year":"2009","journal-title":"Ann Emerg Med"},{"issue":"3","key":"10.1016\/j.prrv.2023.08.003_b0565","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.acap.2019.09.006","article-title":"Medication errors from over-the-counter cough and cold medications in children","volume":"20","author":"Wang","year":"2020","journal-title":"Acad Pediatr"},{"issue":"4","key":"10.1016\/j.prrv.2023.08.003_b0570","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.cpem.2012.09.007","article-title":"Cold and cough medications for children: dangerous and over the counter!","volume":"13","author":"Yust","year":"2012","journal-title":"Clin Pediatr Emerg Med"},{"issue":"3","key":"10.1016\/j.prrv.2023.08.003_b0575","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00006565-199106000-00010","article-title":"Toxicity with dextromethorphan-containing preparations: A literature review and report of two additional cases","volume":"7","author":"Pender","year":"1991","journal-title":"Pediatr Emerg Care"},{"issue":"5","key":"10.1016\/j.prrv.2023.08.003_b0580","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jpeds.2010.05.040","article-title":"Malicious use of pharmaceuticals in children","volume":"157","author":"Yin","year":"2010","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.prrv.2023.08.003_b0585","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-049536","article-title":"Pediatric fatalities associated with over-the-counter cough and cold medications","volume":"148","author":"Halmo","year":"2021","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.prrv.2023.08.003_b0590","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1440-1754.2010.01780.x","article-title":"Restricting cough and cold medicines in children","volume":"48","author":"Isbister","year":"2012","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.prrv.2023.08.003_b0595","unstructured":"Archived: https:\/\/web.archive.org\/web\/20140717013231\/http:\/\/tga.gov.au\/industry\/otc-notices-cough-cold-review-outcomes.htm#.U8cntK3P0Q8(viewed April 2023). [Internet]. Therapeutic Goods Administration. OTC cough and cold medicines for children: final outcomes of TGA review. 15 Aug 2012. ."},{"issue":"5","key":"10.1016\/j.prrv.2023.08.003_b0600","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.jpeds.2013.04.054","article-title":"Effect of cough and cold medication restriction and label changes on pediatric ingestions reported to united states poison centers","volume":"163","author":"Mazer-Amirshahi","year":"2013","journal-title":"J Pediatr"},{"issue":"8","key":"10.1016\/j.prrv.2023.08.003_b0605","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00228-021-03090-4","article-title":"Ivy leaf (Hedera helix) for acute upper respiratory tract infections: an updated systematic review","volume":"77","author":"Sierocinski","year":"2021","journal-title":"Eur J Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.prrv.2023.08.003_b0610","doi-asserted-by":"crossref","first-page":"e2134142","DOI":"10.1001\/jamanetworkopen.2021.34142","article-title":"Prescriptions for codeine or hydrocodone cough and cold medications to US Children and Adolescents Following US Food and Drug Administration Safety Communications","volume":"4","author":"Chua","year":"2021","journal-title":"JAMA Netw Open"}],"container-title":["Paediatric Respiratory Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526054223000477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526054223000477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:37:23Z","timestamp":1761507443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526054223000477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":122,"alternative-id":["S1526054223000477"],"URL":"https:\/\/doi.org\/10.1016\/j.prrv.2023.08.003","relation":{},"ISSN":["1526-0542"],"issn-type":[{"type":"print","value":"1526-0542"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cough medicines for children- time for a reality check","name":"articletitle","label":"Article Title"},{"value":"Paediatric Respiratory Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prrv.2023.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}